[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338489-105":59,"doc-detail-338489-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","neutralization-of-the-autophagy-repressive-tissue-hormone-dbiacbp-enhances-anticancer-immunosurveillance","Neutralization of the autophagy-repressive tissue hormone DBI/ACBP enhances anticancer immunosurveillance","","Plasma levels of the macroautophagy/autophagy inhibitor DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) rise with aging and body mass index (BMI), and both age and obesity are key cancer risk factors. Patients carrying BRCA1, BRCA2, or TP53 cancer predisposition mutations show abnormally high DBI/ACBP levels, and individuals without known syndromes also exhibit elevated levels before imminent diagnosis. Mouse studies indicate that genetic or antibody-mediated DBI/ACBP inhibition can delay cancer development or progression, improving immunosurveillance by modulating effector and regulatory T-cell infiltration during chemoimmunotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/neutralization-of-the-autophagy-repressive-tissue-hormone-dbiacbp-enhances-anticancer-immunosurveillance/338489/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/neutralization-of-the-autophagy-repressive-tissue-hormone-dbiacbp-enhances-anticancer-immunosurveillance/338489.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do DBI/ACBP plasma levels relate to aging and BMI in this study?","Question",{"text":112,"@type":113},"DBI/ACBP plasma concentrations increase with aging and with body mass index (BMI). Age and BMI correlations are statistically independent in human populations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence links elevated DBI/ACBP levels to later cancer development?",{"text":117,"@type":113},"Patients with BRCA1, BRCA2, or TP53 mutations show abnormally high DBI/ACBP levels. Elevated levels are also seen in individuals without known predisposition syndromes before cancer diagnosis, indicating supranormal DBI/ACBP as a risk factor.",{"name":119,"@type":110,"acceptedAnswer":120},"How does DBI/ACBP neutralization affect immune-cell infiltration during chemoimmunotherapy?",{"text":121,"@type":113},"DBI/ACBP neutralization enhances tumor infiltration by non-exhausted effector T cells while reducing infiltration by regulatory T cells. This improves cancer control in several tumor models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338489,1790381546,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":81,"preview_urls":144},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","AUTOPHAGY  \n2024, VOL. 20, NO. 12, 2836–2838  \n[https://doi.org/10.1080/15548627.2024.241](https://doi.org/10.1080/15548627.2024.241)1854  \nAUTOPHAGIC PUNCTUM  \nNeutralization of the autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) enhances anticancer immunosurveillance  \nLéa Montégut a,b, Isabelle Martins a,b, and Guido Kroemer a,b,c  \naCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Paris, France; bMetabolomics and Cell Biology Platforms, Gustave Roussy Institut, Villejuif, France; cDepartment of Biology, Institut du Cancer Paris CARPEM, Hôpital Européen Georges Pompidou, AP-HP, Paris, France  \nABSTRACT  \nThe plasma concentration of the macroautophagy/autophagy inhibitor DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) increases with aging and body mass index (BMI) . Both advanced age and obesity are among the most important risk factors for the development of cancer. We observed that patients with cancer predisposition syndromes due to mutations in BRCA1, BRCA2 and TP53 exhibit abnormally high plasma DBI/ACBP levels. Additionally, patients without known cancer predisposition syndromes also manifest higher DBI/ACBP levels before imminent cancer diagnosis (within 0–3 years) as compared to age and BMI-matched controls who remain cancer-free. Thus, supranormal plasma DBI/ACBP constitutes a risk factor for later cancer development. Mouse experimentation revealed that genetic or antibody-mediated DBI/ACBP inhibition can delay the development or progression of cancers. In the context of chemoimmunotherapy, DBI/ACBP neutralization enhances tumor infiltration by non-exhausted effector T cells but reduces infiltration by regulatory T cells. This resulted in better cancer control in models of breast cancer, non-small cell lung cancer and sarcoma. We conclude that DBI/ACBP constitutes an actionable autophagy checkpoint for improving cancer immunosurveillance.  \nAbbreviation: BMI, body mass index; CTL, cytotoxic T lymphocyte; DBI, diazepam binding inhibitor, acyl-CoA binding protein; mAb, monoclonal antibody; NSCLC, non-small cell lung cancer; PDCD1/PD- 1, programmed cell death 1; scRNA-seq, single-cell RNA sequencing; Treg, regulatory T cell.  \nARTICLE HISTORY  \nReceived 8 September 2024 Revised 23 September 2024 Accepted  \n27 September 2024  \nKEYWORDS  \nAutophagy; cancer;  \nimmunotherapy; metabolism; obesity  \nDBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) functions as an extracellular autophagy checkpoint. Intriguingly, this protein appears to mediate pro-aging effects, commensurate with the established anti-aging effects of autophagy. Thus, knockout of the genes encoding orthologs of DBI/ACBP in yeast and nematodes causes lifespan extension. In human populations, plasma concentrations of DBI/ACBP increase with age and body mass index (BMI), and both these correlations are statistically independent from each other. Additionally, in a population of healthy volunteers enrolled in a longitudinal follow-up of disease development, elevated plasma levels of DBI/ACBP are observed prior to cardiovascular events. In a similar approach, we examined whether measurements of plasma DBI/ACBP would make it possible to predict the development of cancer, another age-related disease, in still (apparently) healthy individuals [ 1] . We found that neoplastic disease is preceded by a surge in plasma DBI/ACBP that is significant compared to individuals that are matched for major epidemiological characteristic (such as sex, age, BMI and known risk factors including tobacco abuse) but do not develop cancer (Figure 1A) . This observation suggests that DBI/ACBP is not only a biomarker of chronological aging – because it increases with age measured in years –  \nbut also a biomarker of biological aging – because its elevation precedes the development of age-related diseases.  \nKnowing t","cbCaimoiRdvSDslm","https://ap.wps.com/l/cbCaimoiRdvSDslm","pdf",481613,"English","# Abstract\n## Key Findings and Human Evidence\n## Animal Experiments and Mechanistic Insights\n## Clinical Implications and Conclusion","[{\"question\":\"How do DBI/ACBP plasma levels relate to aging and BMI in this study?\",\"answer\":\"DBI/ACBP plasma concentrations increase with aging and with body mass index (BMI). Age and BMI correlations are statistically independent in human populations.\"},{\"question\":\"What evidence links elevated DBI/ACBP levels to later cancer development?\",\"answer\":\"Patients with BRCA1, BRCA2, or TP53 mutations show abnormally high DBI/ACBP levels. Elevated levels are also seen in individuals without known predisposition syndromes before cancer diagnosis, indicating supranormal DBI/ACBP as a risk factor.\"},{\"question\":\"How does DBI/ACBP neutralization affect immune-cell infiltration during chemoimmunotherapy?\",\"answer\":\"DBI/ACBP neutralization enhances tumor infiltration by non-exhausted effector T cells while reducing infiltration by regulatory T cells. This improves cancer control in several tumor models.\"}]","Neutralization of the autophagy-repressive tissue hormone DBI/ACBP enhances anticancer immunosurveillance | PDF",1790023814,[145,149,153],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d92d38d4ee2ab94184c54db88846276e.webp",983,1280,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b740d70cf9fce4732dbcf733848f3e3.webp",982,1278,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eccd56508f5fed33e4b4818c6a9216c2.webp",981,1277]